BRCA1/2 testing in patients with breast and ovarian cancer

BRCA1/2 testing in patients with breast and ovarian cancer

Bibliographic Details
Main Authors:	Perović Jelica, Branković-Magić Mirjana, Janković Radmila
Format:	Article
Language:	English
Published:	Institute of Oncology, Sremska Kamenica, Serbia 2002-01-01
Series:	Archive of Oncology
Subjects:	breast neoplasms ovarian neoplasms genetic techniques
Online Access:	http://www.doiserbia.nb.rs/img/doi/0354-7310/2002/0354-73100203239P.pdf

Similar Items

Breast cancer susceptibility genes: Options for those carrying BRCA1 mutations
by: Branković-Magić Mirjana, et al.
Published: (2002-01-01)

Molecular genetics of breast cancer: Possible clinical implication
by: Branković-Magić Mirjana, et al.
Published: (2002-01-01)

Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?
by: Branković-Magić Mirjana, et al.
Published: (2006-01-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)

Familial aggregation of breast/ovarian cancer: age of onset along subsequent generations in Brazil
by: Koifman Rosalina Jorge, et al.
Published: (1998-01-01)

Metastasis of Ovarian Cancer to Breast: A Case Report and Review of Imaging Manifestations
by: Wang J, et al.
Published: (2020-12-01)

Joint disease mapping of breast, uterine, and ovarian cancers in cities of Isfahan Province from 2005 to 2010 using spatial shared component model
by: Marzieh Nasr, et al.
Published: (2021-01-01)

Diagnostic Accuracy of Whole-Body Computed Tomography for Incidental Ovarian Tumors in Patients with Prior Breast Cancer
by: Pei-Ching Huang, et al.
Published: (2022-01-01)

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report
by: Ryutaro Mori, et al.
Published: (2017-06-01)

Estrogen dependence of breast carcinoma: The role of estrogen-regulated proteins
by: Matas Milica, et al.
Published: (2002-01-01)

Identification and characterisation of single nucleotide polymorphisms in cytochrome P450 2D6 gene in Malaysian breast cancer patients
by: Chin, Fee Wai
Published: (2012)

Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors
by: Gyongyver Szentmartoni, et al.
Published: (2024-03-01)

Ovarian cancer : new research /
by: Bardos, A. P.
Published: (2009)

Risk factors of ovarian cancer among women at selected hospitals in the Klang Valley, Malaysia
by: John, Ugwu Osmong
Published: (2019)

Breast cancer metastasis to the conjunctiva
by: Bobić-Radovanović Anica, et al.
Published: (2013-01-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

High level of EGF-R expression in carcinomatous skin invasion: Does it reflect the tissue characteristics of the breast carcinoma aggressiveness?
by: Nešković-Konstantinović Zora B., et al.
Published: (2002-01-01)

Efficacy of chemotherapy in patients with HR+/HER2–Invasive lobular breast cancer
by: Marita Yaghi, et al.
Published: (2023-01-01)

BRCA2 reversion mutation confers resistance to olaparib in breast cancer
by: Shinya Yamamoto, et al.
Published: (2023-06-01)

<b>Risk assessment for breast cancer and BRCA mutations in women with personal and familial history</b> - doi: 10.4025/actascihealthsci.v35i2.12134
by: Leandro da Silva Clementino, et al.
Published: (2013-06-01)

Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement
by: Mathias Schwartz, et al.
Published: (2024-02-01)

Ovarian carcinoma presenting as cutaneous nasal metastasis
by: Ana Marta António, et al.
Published: (2016-10-01)

Intramammary Nodal Metastasis from Ovarian Cancer: A Case Report
by: Omar Hamdy, et al.
Published: (2019-07-01)

The Emerging Role of Chitosan-based Polymeric Nanoparticles in the Diagnosis and Treatment of Gynecological Cancers
by: Babak Arji Roudsari, et al.
Published: (2023-10-01)

Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
by: Gi Won Shin, et al.
Published: (2020-03-01)

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
by: Andrea Nañez, et al.
Published: (2022-02-01)

Duodenal and Colonic Metastases of Ovarian Neoplasm
by: Sandra Barbeiro, et al.
Published: (2015-07-01)

Endometriosis and Ovarian Cancer: Should we be worried? Five Cases Report and Literature Review
by: José Silva Pereira, et al.
Published: (2023-12-01)

Endometriosis and Ovarian Cancer: Should we be worried? Five Cases Report and Literature Review
by: José Silva Pereira, et al.
Published: (2023-12-01)

Endometriosis and Ovarian Cancer: Should we be worried? Five Cases Report and Literature Review
by: José Silva Pereira, et al.
Published: (2023-12-01)

Photodynamic Therapy for Gynecological Diseases and Breast Cancer
by: Natashis Shishkova, et al.
Published: (2012-03-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

Patterns of care and outcomes for endometrial and ovarian cancers in botswana 2015–2021
by: Christian Lumley, et al.
Published: (2023-10-01)

Focus on breast cancer research /
by: Yao, Andrew P.
Published: (2004)

Dermoscopy of inflammatory breast cancer
by: María Gabriela Vallone, et al.
Published: (2018-03-01)

Borderline ovarian tumors
by: Mastilović Katarina, et al.
Published: (2006-01-01)

Prevention of breast cancer complications
by: Branković Magdalena, et al.
Published: (2002-01-01)

Evaluation of the relative frequency of Epstein–Barr virus infection in patients with recurrent breast cancer compared with patients with nonrecurrent breast cancer
by: Reza Eshraghi Samani, et al.
Published: (2023-01-01)

Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2
by: Lauren Clarfield, et al.
Published: (2022-03-01)